An Advanced LC–MS/MS Platform for the Analysis of Specialized Pro-Resolving Lipid Mediators

Chromatographia

Volumn 78, Issue 5-6, 2015, Pages 391-401

  Jónasdóttir, Hulda S ^a   Ioan Facsinay, Andreea ^a   Kwekkeboom, Joanneke ^a   Brouwers, Hilde ^a   Zuurmond, Anne Marie ^b   Toes, René ^a   Deelder, André M ^a   Giera, Martin ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

Author keywords

EPA; Inflammation resolution; LC MS; LTE4; Pro resolving mediators; Synovial fluid

Indexed keywords

CELL EXTRACT; ICOSAPENTAENOIC ACID; IONOPHORE; LIPID; METHANOL; POLYUNSATURATED FATTY ACID; SPECIALIZED PRO RESOLVING LIPID; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; ISOLATION AND PURIFICATION; LIPID ANALYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; SYNOVIAL FLUID; VALIDATION STUDY;

EID: 84924111660     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1007/s10337-014-2779-5     Document Type: Article

References (20)

1. Serhan CN, Petasis NA (2011) Resolvins and protectins in inflammation resolution. Chem Rev 111(10):5922–5943. doi:10.1021/cr100396c
2. von Schacky C, Marcus AJ, Safier LB, Ullman HL, Islam N, Broekman MJ, Fischer S (1990) Platelet-neutrophil interactions. 12S,20- and 5S,12S-dihydroxyeicosapentaenoic acids: two novel neutrophil metabolites from platelet-derived 12S-hydroxyeicosapentaenoic acid. J Lipid Res 31(5):801–810
3. Isobe Y, Arita M, Matsueda S, Iwamoto R, Fujihara T, Nakanishi H, Taguchi R, Masuda K, Sasaki K, Urabe D, Inoue M, Arai H (2012) Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid. J Biol Chem 287(13):10525–10534. doi:10.1074/jbc.M112.340612
4. Schif-Zuck S, Gross N, Assi S, Rostoker R, Serhan CN, Ariel A (2011) Saturated-efferocytosis generates pro-resolving CD11blow macrophages: modulation by resolvins and glucocorticoids. Eur J Immunol 41(2):366–379. doi:10.1002/eji.201040801
5. Hsiao H-M, Sapinoro RE, Thatcher TH, Croasdell A, Levy EP, Fulton RA, Olsen KC, Pollock SJ, Serhan CN, Phipps RP, Sime PJ (2013) A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation. PLoS ONE 8(3):e58258. doi:10.1371/journal.pone.0058258
6. Serhan CN (2010) Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 177(4):1576–1591. doi:10.2353/ajpath.2010.100322
7. Serhan CN, Recchiuti A (2012) Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation. Front Immunol. doi:10.3389/fimmu.2012.00298
8. Serhan CN, Dalli J, Karamnov S, Choi A, Park C-K, Xu Z-Z, Ji R-R, Zhu M, Petasis NA (2012) Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J 26(4):1755–1765. doi:10.1096/fj.11-201442
9. Bannenberg G, Serhan CN (2010) Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochimica et Biophysica Acta 1801(12):1260–1273. doi:10.1016/j.bbalip.2010.08.002
10. Kortz L, Dorow J, Becker S, Thiery J, Ceglarek U (2013) Fast liquid chromatography–quadrupole linear ion trap-mass spectrometry analysis of polyunsaturated fatty acids and eicosanoids in human plasma. J Chromatogr B 927:209–213. doi:10.1016/j.jchromb.2013.03.012
11. Giera M, Ioan-Facsinay A, Toes R, Gao F, Dalli J, Deelder AM, Serhan CN, Mayboroda OA (2012) Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC–MS/MS. Biochim Biophys Acta 1821(11):1415–1424. doi:10.1016/j.bbalip.2012.07.011
12. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC–MS/MS. Anal Chem 75(13):3019–3030. doi:10.1021/ac020361s
13. Mas E, Croft KD, Zahra P, Barden A, Mori TA (2012) Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin Chem 58(10):1476–1484. doi:10.1373/clinchem.2012.190199
14. Shearer GC, Harris WS, Pedersen TL, Newman JW (2010) Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. J Lipid Res 51(8):2074–2081. doi:10.1194/jlr.M900193-JLR200
15. Strassburg K, Huijbrechts AL, Kortekaas K, Lindeman J, Pedersen T, Dane A, Berger R, Brenkman A, Hankemeier T, Duynhoven J, Kalkhoven E, Newman J, Vreeken R (2012) Quantitative profiling of oxylipins through comprehensive LC–MS/MS analysis: application in cardiac surgery. Anal Bioanal Chem 404(5):1413–1426. doi:10.1007/s00216-012-6226-x
16. Massey KA, Nicolaou A (2013) Lipidomics of oxidized polyunsaturated fatty acids. Free Radic Biol Med 59:45–55. doi:10.1016/j.freeradbiomed.2012.08.565
17. Sala A, Kayganich K, Zirrolli JA, Murphy RC (1991) Negative ion tandem mass spectrometry of leukotriene E4 and LTE4 metabolites: identification of LTE4 in human urine. J Am Soc Mass Spectrom 2(4):314–321. doi:10.1016/1044-0305(91)80023-Z
18. Dalli J, Serhan CN (2012) Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 120(15):e60–e72. doi:10.1182/blood-2012-04-423525
19. Gomolka B, Siegert E, Blossey K, Schunck W-H, Rothe M, Weylandt KH (2011) Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples. Prostaglandins Other Lipid Mediat 94(3–4):81–87. doi:10.1016/j.prostaglandins.2010.12.006
20. Oh SF, Dona M, Fredman G, Krishnamoorthy S, Irimia D, Serhan CN (2012) Resolvin E2 formation and impact in inflammation resolution. J Immunol 188(9):4527–4534. doi:10.4049/jimmunol.1103652